I must admit, I was expecting more than just a 4C - arghhhh the elongated & painful wait continues
There's a few good bits in the announcement today, but I was hoping to hear more forward statements, which does not normally come in a 4C which is reflective of the last quarter financial and operation activities.
"Regarding COVID ARDS, Mesoblast met with the FDA this week to determine the registrationpathway for approval of remestemcel-L in this indication, with formal minutes expected incoming weeks."
Surely, now Novartis has enough information to get on with it!
As for the SP today, I'm not too sure what to expect.
So all I can say is GL MSB'ers and stay strong.
MSB Trading 2021 - paradigm shift, page-6652
-
- There are more pages in this discussion • 3,559 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.31 |
Change
0.040(3.16%) |
Mkt cap ! $1.490B | |||
| Open | High | Low | Value | Volume |
| $1.28 | $1.32 | $1.26 | $3.433M | 2.652M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 39558 | $1.30 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.31 | 21776 | 3 |
View Market Depth
| Last trade - 16.10pm 28/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |